BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28421817)

  • 1. Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases.
    Ohkouchi S; Akasaka K; Ichiwata T; Hisata S; Iijima H; Takada T; Tsukada H; Nakayama H; Machiya JI; Irokawa T; Ogawa H; Shibata Y; Ichinose M; Ebina M; Nukiwa T; Kurosawa H; Nakata K; Tazawa R
    Ann Am Thorac Soc; 2017 Aug; 14(8):1298-1304. PubMed ID: 28421817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis.
    Yamamoto H; Yamaguchi E; Agata H; Kandatsu N; Komatsu T; Kawai S; Baba K; Awaya T; Nishikomori R; Tsurusawa M; Nakata K
    Pediatr Pulmonol; 2008 Aug; 43(8):828-30. PubMed ID: 18618617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
    Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined-modality therapy for pulmonary alveolar proteinosis in a remote setting: a case report.
    Boyce DSK; Lee JW; Shah P; Freeman JH; Aboudara MC; Hostler DC
    BMC Pulm Med; 2019 Mar; 19(1):61. PubMed ID: 30866900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary alveolar proteinosis: time to shift?
    Papiris SA; Tsirigotis P; Kolilekas L; Papadaki G; Papaioannou AI; Triantafillidou C; Papaporfyriou A; Karakatsani A; Kagouridis K; Griese M; Manali ED
    Expert Rev Respir Med; 2015 Jun; 9(3):337-49. PubMed ID: 25864717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Patient with autoimmune alveolar proteinosis who did not respond to GM-CSF inhalation therapy and underwent repeated whole-lung lavage].
    Ueda Y; Matsuo K; Tsushima M; Mizuta M; Fujiwara K; Yonei T; Sato T
    Nihon Kokyuki Gakkai Zasshi; 2009 Sep; 47(9):833-8. PubMed ID: 19827590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole lung lavage combined with Granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis.
    Yu Hy; Sun Xf; Wang Yx; Xu Zj; Huang H
    BMC Pulm Med; 2014 May; 14():87. PubMed ID: 24886114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients.
    Campo I; Carey BC; Paracchini E; Kadija Z; De Silvestri A; Rodi G; De Amici M; Torre C; Zorzetto M; Griese M; Meloni F; Corsico AG; Trapnell BC; Mariani F
    Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 37973175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-Macrophage Colony-Stimulating Factor Inhalation Therapy for Severe Pulmonary Alveolar Proteinosis.
    Zhen G; Li D; Jiang J; Weng Y
    Am J Ther; 2020 Mar; 28(2):e171-e178. PubMed ID: 31513019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profiles associated with disease severity and prognosis of autoimmune pulmonary alveolar proteinosis.
    Akasaka K; Amano M; Nakamura T; Nishizawa T; Yamakawa H; Sato S; Aoki A; Shima K; Matsushima H; Takada T
    Respir Investig; 2024 Jul; 62(4):610-616. PubMed ID: 38705133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
    Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
    Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.
    Tazawa R; Nakata K; Inoue Y; Nukiwa T
    Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Alveolar Proteinosis Syndrome.
    Suzuki T; Trapnell BC
    Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis].
    Rodríguez Portal JA; Rodríguez Becerra E; Sánchez Garrido A
    Arch Bronconeumol; 2009 Mar; 45(3):150-2. PubMed ID: 19286115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report.
    Sato S; Akasaka K; Ohta H; Tsukahara Y; Kida G; Tsumiyama E; Kusano K; Oba T; Nishizawa T; Kawabe R; Yamakawa H; Amano M; Matsushima H; Takada T
    BMC Pulm Med; 2020 Apr; 20(1):84. PubMed ID: 32252718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses.
    Sheng G; Chen P; Wei Y; Chu J; Cao X; Zhang HL
    Respir Res; 2018 Aug; 19(1):163. PubMed ID: 30165864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multidisciplinary assessment of effects, safety and procedure of whole lung lavage for 8 patients with autoimmune pulmonary alveolar proteinosis].
    Sugimoto C; Arai T; Nishiyama A; Inoue Y; Kagawa T; Akira M; Matsumuro A; Hirose M; Kitaichi M; Hayashi S; Inoue Y
    Nihon Kokyuki Gakkai Zasshi; 2011 Aug; 49(8):569-76. PubMed ID: 21894771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Pulmonary Alveolar Proteinosis That Improved after a COVID-19 Episode.
    Yanagisawa A; Takimoto T; Shintani R; Kobayashi T; Hirose M; Arai T; Inoue Y
    Intern Med; 2023 Aug; 62(15):2237-2241. PubMed ID: 37164675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis for treatment of pulmonary alveolar proteinosis.
    Luisetti M; Rodi G; Perotti C; Campo I; Mariani F; Pozzi E; Trapnell BC
    Eur Respir J; 2009 May; 33(5):1220-2. PubMed ID: 19407056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile.
    Ito M; Nakagome K; Ohta H; Akasaka K; Uchida Y; Hashimoto A; Shiono A; Takada T; Nagata M; Tohyama J; Hagiwara K; Kanazawa M; Nakata K; Tazawa R
    BMC Pulm Med; 2017 Feb; 17(1):40. PubMed ID: 28212655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.